Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer
Loibl, Sibylle; Park, Yeon Hee; Shao, Zhiming; Huang, Chiun-Sheng; Barrios, Carlos; Abraham, Jame; Prat, Aleix; Niikura, Naoki; Im, Seock-Ah; Li, Wei; Li, Huiping; Wang, Yongsheng; Yao, Herui; Kim, Sung-Bae; Geng, Cui-zhi; Rodriguez Pantigoso, Wuilbert; Ramirez Godinez, Francisco Javier; Song, Chuangui; Ching Chang, Yuan; Antoniazzi, Augusto; Chen, Shin-Cheh; Li, Zhigao; Nowecki, Zbigniew; Lim, Joline; Mathias, Elton; Sato, Yuta; Lu, Wenjing; Abdel-Monem, Hanan; Untch, Michael; Geyer, Charles E. Share Save Share Save Share Save Share Save Share Save Efficacy and safety of KN026 and docetaxel for HER2-positive breast cancer: a phase II clinical trialMa, Jianli; Wang, Jingxuan; Xu, Ting; Ouyang, Quchang; Wang, Xiaojia; Wang, Jingfen; Gan, Lu; Ouyang, Zhong; Lin, Daren; Sun, Tao; Shan, Changping; Yao, Herui; Zhang, Baochun; Li, Zhengguang; Zhuang, Zhixiang; Lu, Ying; Yang, Hongwei; Huang, Jian; Yang, Xingwang; Sun, Hongmei; Zhang, Qingyuan Share Save Phase I Trial of Upamostat Combined With Gemcitabine in Locally Unresectable or Metastatic Pancreatic Cancer: Safety and Preliminary Efficacy AssessmentLai, Xiuping; Cheng, Di; Xu, Huixin; Wang, Jingshu; Lv, Xiaozhi; Yao, Herui; Li, Liuning; Wu, Junyan; Ye, Suiwen; Li, Zhihua Share Save Multi-center, retrospective GUIDANCE001 trial comparing TACE with or without tyrosine kinase and immune checkpoint inhibitors as conversion therapy to treat unresectable hepatocellular carcinoma: Survival benefit in intermediate or advanced, but not early, stagesYang, D.; Zeng, F-J.; Nong, J-L.; Liu, J.; Yao, H-B.; Ye, L.; Peng, N.; Li, W-F.; Wu, P-S.; Qin, C.; Su, Z.; Ou, J-J.; Dong, X-F.; Yan, Y-H.; Zhong, T-M.; Wu, M-S.; Chen, Y-Z.; Wang, G-D.; Ma, L.; Zhong, J-H. Share Save Share Save Nab-paclitaxel, cisplatin, and capecitabine versus cisplatin and gemcitabine as first line chemotherapy in patients with recurrent or metastatic nasopharyngeal carcinoma: randomised phase 3 clinical trialLiu, Guo-Ying; Ye, Yan-Fang; Jiang, Yao-Fei; Chen, Gina Jinna; Xia, Wei-Xiong; Huang, Yi-Sheng; Gao, Tian-Sheng; Liu, Yi-Min; Hou, Ya-Ting; Li, Jian-Fei; Liu, Jia-Hao; Lu, Nian; Chen, Chang-Long; Ke, Liang-Ru; Liang, Hu; Bei, Wei-Xin; Li, Wang-Zhong; Dong, Shu-Hui; Liu, Qin; Xie, Changqing; Yao, He-Rui; Xiang, Yan-Qun Share Save Distinct ER and PR expression patterns significantly affect the clinical outcomes of early HER2-positive breast cancer: A real-world analysis of 871 patients treated with neoadjuvant therapyChen, Haizhu; Gui, Xiujuan; Zhou, Ziwei; Su, Fengxi; Gong, Chang; Li, Shunrong; Wu, Wei; Rao, Nanyan; Liu, Qiang; Yao, Herui Share Save Deep learning-based multi-modal data integration enhancing breast cancer disease-free survival predictionWang, Zehua; Lin, Ruichong; Li, Yanchun; Zeng, Jin; Chen, Yongjian; Ouyang, Wenhao; Li, Han; Jia, Xueyan; Lai, Zijia; Yu, Yunfang; Yao, Herui; Su, Weifeng Share Save Artificial intelligence enables precision diagnosis of cervical cytology grades and cervical cancerWang, Jue; Yu, Yunfang; Tan, Yujie; Wan, Huan; Zheng, Nafen; He, Zifan; Mao, Luhui; Ren, Wei; Chen, Kai; Lin, Zhen; He, Gui; Chen, Yongjian; Chen, Ruichao; Xu, Hui; Liu, Kai; Yao, Qinyue; Fu, Sha; Song, Yang; Chen, Qingyu; Zuo, Lina; Wei, Liya; Wang, Jin; Ouyang, Nengtai; Yao, Herui Share Save BL-M07D1, an antibody- drug conjugate directed to HER2 in patients with locally advanced or metastatic Breast Cancer with HER2-positive/low-expression and other solid tumors: Results from a first-in-human phase 1 studySong, Erwei; Yao, Herui; Sun, Meili; Zong, Hong; Lin, Rongbo; Zou, Wen; Ding, Muran; Yu, Jing; Xiao, Sa; Wang, Hongwei; Zhu, Hai; Olivo, Martin; Zhu, Yi Share Save Overall survival results from EVER-132-001, a phase 2b single-arm study of sacituzumab govitecan in Chinese patients with metastatic triple-negative breast cancerMa, Fei; Wang, Shusen; Tong, Zhongsheng; Li, Wei; Wu, Xinhong; Wang, Xiaojia; Sun, Tao; Pan, Yueyin; Yao, Herui; Wang, Xian; Luo, Ting; Yang, Jin; Zeng, Xiaohua; Zhao, Weihong; Komatsubara, Kimberly; Nakamura, Rachel; Lai, Catherine; Zhang, Bo; Cong, Xiuyu; Xu, Binghe Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
ANNALS OF ONCOLOGY.png)
